Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
ProtaGene Appoints New Scientific and Commercial Leadership to Support Evolving Needs of Biologic and Cell & Gene Therapy Innovators
ProtaGene, a leading global contract research organization focused on advanced analytics in biologics and cell […]
Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure […]
Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK
The Ethypharm Group, a European pharmaceutical company focused on the Central Nervous System and Hospital […]
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
Vesigen Therapeutics, a biotechnology company developing transformative therapeutics by engineering naturally existing vesicles, today announced […]
BioSenic appoints Yves Sagot as Independent Director
BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and cell repair, today announces […]
Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors
Kinnate Biopharma, a clinical-stage precision oncology company, has announced that its board of directors has […]
Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment […]
Akston Biosciences Strengthens Board with Addition of John T. Preston
Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John Preston, a founder of […]
Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors
Gandeeva Therapeutics, a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic […]
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more